Drug Database
Back to search

Poland· PL-100538965

Essentiale Forte

A phospholipide product containing phospholipidum essentiale, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 2 of our 19 countries.

ATC A05BA10

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedEssentiale ForteATCA05BA10REGISTER NO.PL-100538965PACKS LISTED4CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about phospholipidum essentialeAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Phospholipide is registered in 2 of 19 countries.

Countries holding a registration under ATC A05BA10 (phospholipide), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 2 of them publish a price we can compare per daily dose
Search phospholipide products by name

Phospholipide · ATC A05BA10

2 / 19 countries

  • Czechiaprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Phospholipidum essentiale
Manufacturer
InPharm Sp. z o.o.
Country
Poland (PL)
ATC code
A05BA10
ATC class
Phospholipide
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

  • gtin
    05909991602048
  • gtin
    05909991602055
  • gtin
    05909991602062
  • gtin
    05909991602079

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under A05BA10

Phospholipide, as other registers publish it.

All phospholipide products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e251a9f3-2dc2-4621-81c4-73037b1a4f5b
GET /v1/drugs/e251a9f3-2dc2-4621-81c4-73037b1a4f5b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki twarde",
  "source": "urpl",
  "strength": "300 mg",
  "packaging": "05909991602048 ¦ OTC ¦ 167169\n50 kaps.\n05909991602055 ¦ OTC ¦ 167170\n90 kaps.\n05909991602062 ¦ OTC ¦ 167171\n100 kaps.\n05909991602079 ¦ OTC ¦ 167172\n180 kaps.",
  "substance": "Phospholipidum essentiale 300 mg",
  "common_name": "Phospholipidum essentiale",
  "pl_product_id": "100538965",
  "pozwolenie_nr": "201/26",
  "auth_procedure": "IR",
  "authorisation_validity": "2031-05-19"
}
API referenceMCP serverPlans

See everything about phospholipide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console